Quantitative analysis of the effect of docetaxel-induced edema on quality of life in patients with breast cancer and related factors: a prospective cohort study

Table 2 Relationship between systemic edema and quality of life score at five assessment time points

	Vitality		Physical aspect		Mental aspect		Social aspect		Total QOL score
	Mean (SD)	*P-value*	Mean (SD)	*P-value*	Mean (SD)	*P-value*	Mean (SD)	*P-value*	Mean (SD)	*P-value*
Baseline										-
edema	25.28(4.72)	0.987	20.92(3.50)	0.582	18.48(4.31)	0.831	13.96(3.86)	0.718	83.32(15.36)	0.626
no edema	25.25(5.63)	0.987	20.25(3.28)	0.582	18.17(3.81)	0.831	13.42(5.02)	0.718	80.67(15.32)	0.626
Intermediate period
edema	23.44(5.54)	0.487	19.84(3.59)	0.216	17.88(3.78)	0.621	15.28(3.45)	0.431	81.12(13.66)	0.214
no edema	22.17(4.22)	0.487	18.33(2.96)	0.216	17.25(3.17)	0.621	14.17(4.95)	0.431	75.25(12.20)	0.214
End of treatment
edema	21.44(5.29)	0.772	18.80(3.81)	0.293	17.92(4.24)	0.259	14.92(4.17)	0.631	77.68(15.46)	0.398
no edema	22.00(5.83)	0.772	17.33(4.14)	0.293	16.25(3.93)	0.259	14.17(4.93)	0.631	72.92(16.70)	0.398
Post-treatment 1 M
edema	20.75(5.35)	0.521	18.33(4.26)	0.625	16.63(4.60)	0.615	15.04(3.51)	0.888	75.17(13.35)	0.677
no edema	22.00(5.14)	0.521	19.09(4.11)	0.625	17.45(4.20)	0.615	15.27(6.13)	0.888	77.36(16.46)	0.677
Post-treatment 2 M
edema	22.91(5.46)	0.480	20.00(2.86)	0.306	18.39(3.49)	0.709	14.83(3.50)	0.768	80.13(13.29)	0.643
no edema	24.33(5.81)	0.480	21.17(3.66)	0.306	18.92(4.66)	0.709	14.33(6.37)	0.768	82.58(17.29)	0.643

ISSN: 1472-6874